Motor Neurone Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial
AbstractObjectivesPrimary Objective• To assess the efficacy of Ayurveda interventions and Yoga in rehabilitation of COVID-19 cases suffering with long term effects of COVID 19 as compared to WHO Rehabilitation Self-Management after COVID-19- Related Illness.Secondary Objective• To assess the safety of Ayurvedic interventions in cases suffering with long term effects of COVID 19Trial designMulti-centric, randomized, controlled, parallel group, open-label, exploratory study. The study duration is 9 months and the intervention period is 90 days from the day of enrolment of the participant.ParticipantsPatients of either se...
Source: Trials - June 3, 2021 Category: Research Source Type: clinical trials
A Study of Monepantel in Individuals With Motor Neurone Disease
Condition: Motor Neuron Disease Intervention: Drug: Monepantel Sponsors: PharmAust Ltd; FightMND; Calvary Health Care Bethlehem; Macquarie University, Australia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 20, 2021 Category: Research Source Type: clinical trials
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial
Condition: Motor Neuron Disease, Amyotrophic Lateral Sclerosis Interventions: Drug: Memantine Hydrochloride Oral Solution; Drug: Trazodone Hydrochloride oral solution; Drug: Placebo oral solution Sponsors: University of Edinburgh; University College, London; University of Warwick; NHS Lothian Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2020 Category: Research Source Type: clinical trials